Supplemental figure 2. Correlations of circulating VEGF, soluble VEGFR1 and soluble VEGFR2 with sex, smoking history and age in IPF. Plasma VEGF, soluble VEGFR1 and soluble VEGFR2 levels in IPF patients (n=41) were separated based on male (n=32) or female (n=9) basis and compared (A), comparisons on smoking history (B) were also conducted. Bars represent the mean ± S.E.M. The correlations between plasma VEGF levels and age of IPF patient (C), FVC percent predicted (D) and DLCO percent predicted (E). Each data point is an individual patient (n = 41). No statistical difference was observed in any of the comparisons. 
